NCT03148925View on ClinicalTrials.gov

Safety and Pharmacodynamcis of SELA-070 Nicotine Vaccine in Smokers

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 11, 2017

Primary Completion Date

October 18, 2018

Study Completion Date

October 18, 2018

Conditions
Smoking Cessation
Interventions
BIOLOGICAL

SELA-070

Sub-cutaneous injection, multiple dose

BIOLOGICAL

Saline

Sub-cutaneous injection, multiple dose

Trial Locations (1)

Unknown

SGS LSS Clinical Pharmacology Unit, Antwerp

All Listed Sponsors
lead

Selecta Biosciences, Inc.

INDUSTRY

NCT03148925 - Safety and Pharmacodynamcis of SELA-070 Nicotine Vaccine in Smokers | Biotech Hunter | Biotech Hunter